P58 Economic evaluation of the GORE® VIATORR® stent in patients with complications of severe cirrhosis – ascites and bleeding: a UK cost-utility analysis
P58 Economic evaluation of the GORE® VIATORR® stent in patients with complications of severe cirrhosis – ascites and bleeding: a UK cost-utility analysis